● TIER 3 — Information onlyGRADE B- (one placebo RCT)Immune / thymic
Cycloferon (meglumine acridonacetate)
Origin: Russia (Polysan). Citations verified: yes. 3 human study record(s) in the FitClinicMD studies database.
FDA status
Not an FDA-approved product
Compounding (503A/503B)
Status varies — see notes
DEA
Not listed as controlled
WADA (sport)
Not specified
Mechanism
Low-molecular-weight interferon inducer (non-peptide).
Human evidence · 3
Results publication 2025.
2025RCTn=166
Cycloferon PEP trial.
RCTn=166
Cycloferon influenza multicenter randomized study.
Reference only. This page summarizes publicly available regulatory and research information about Cycloferon (meglumine acridonacetate). It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.